Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sympathetic trunk, also known as the sympathetic chain, is an anatomical structure comprising a paired series of ganglia located paravertebrally from the base of the skull to the coccyx [1][2]. It serves as a critical conduit for the autonomic nervous system, facilitating the transmission of sympathetic signals that govern the body's involuntary "fight-or-flight" responses, such as thermoregulation, heart rate modulation, and vascular tone [1]. While the sympathetic trunk is not a specific molecule or receptor, it is a significant clinical target for interventional procedures, including surgical sympathectomy and chemical nerve blocks [3]. These interventions aim to interrupt overactive sympathetic pathways in patients suffering from conditions like primary focal hyperhidrosis, Raynaud's phenomenon, and complex regional pain syndrome (CRPS) [3][4]. Pharmacological interaction at the trunk level typically involves local anesthetics that inhibit action potential propagation or neurolytic agents used for permanent disruption of neural signaling [4].
Intervention at the sympathetic trunk typically involves the use of local anesthetics to block voltage-gated sodium channels, inhibiting nerve conduction, or the application of neurolytic agents to cause chemical destruction of the ganglia [3][4].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sympathetic trunk.